Skip Navigation

Filter Results

1035 News Releases Found

Panos A. Konstantinopoulos, MD, PhD
News Releases
3/19/2020

Scientists identify factors for predicting which patients with ovarian cancer won’t benefit from immunotherapy-PARP inhibitor combination

  • Precision Cancer Medicine
  • Immunotherapy
  • Ovarian Cancer
Heather A. Parsons, MD, MPH
News Releases
3/13/2020

Personalized blood biopsies demonstrate potential as early-warning signal of breast cancer recurrence

  • Precision Cancer Medicine
Pancreatic Cancer Cells
News Releases
3/5/2020

Dana-Farber research team awarded Pancreatic Cancer Collective “New Therapies Challenge” grant

  • Research
  • Pancreatic Cancer
_
News Releases
3/2/2020

Six new members elected to the Board at Dana-Farber Cancer Institute

Katherine A. Janeway, MD, MMSc
News Releases
2/27/2020

The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

  • Soft Tissue Sarcomas, Childhood
  • Bone Cancers, Childhood
Jonathan D. Schoenfeld, MD, MPhil, MPH
News Releases
2/27/2020

Pre-operative immunotherapy shows promise in oral cancers

  • Immunotherapy
  • Head and Neck Cancer
Laurie H. Glimcher, MD and Ansbert Gadicke, MD (photo credit: Justin Knight, Dana-Farber Cancer Institute)
News Releases
2/26/2020

MPM Capital Announces $100M Oncology Innovations Fund as Part of Novel Venture Philanthropy Collaboration with Dana-Farber Cancer Institute  

  • Research
Ramesh A. Shivdasani, MD, PhD
News Releases
2/20/2020

A case of reverse development: Dana-Farber scientists solve long-debated puzzle of how the intestine heals itself

  • Research
Toni Choueiri, MD
News Releases
2/15/2020

Novel targeted drug shows promise in advanced kidney cancer

  • Research
  • Kidney Cancer